Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Breast Cancer Research and Treatment|October 1, 2009
Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma modelMichele L Martin, Erika M Wall, Emily Sandwith, et al.
BMC Cancer|November 8, 2002
RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancerEthan D Emberley, R Daniel Gietz, J Darren Campbell, et al.
Biopreservation and Biobanking|January 28, 2020
Comparison and Analysis of Two Internationally Recognized Biobanking StandardsTamsin Tarling, Sheila O'Donoghue, Rebecca Barnes, et al.
DNA and Cell Biology|February 8, 2006
Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouseAnne A A Blanchard, Peter H Watson, Robert P C Shiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2012
CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancerJulie S Nielsen, Rob A Sahota, Katy Milne, et al.
Endocrine|September 30, 2003
Relationship between mammaglobin expression and estrogen receptor status in breast tumorsXiao-feng Guan, Mohammad K Hamedani, Adewale Adeyinka, et al.
Cureus|January 10, 2018
Malignant Epithelial Transformation in Phyllodes Tumor: A Population-Based Case SeriesRalph L Widya, Myra F Rodrigues, Pauline T Truong, et al.
Cancer Immunology, Immunotherapy : CII|April 8, 2009
Mammary tumors with diverse immunological phenotypes show differing sensitivity to adoptively transferred CD8+ T cells lacking the Cbl-b geneTaimei Yang, Michele L Martin, Julie S Nielsen, et al.
Plos One|July 31, 2009
Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factorsKaty Milne, Martin Köbel, Steven E Kalloger, et al.
NPJ Precision Oncology|October 17, 2025
Circulating enolase 1 as a diagnostic biomarker for early-stage breast cancerNikki Salmond, Renata Moravcova, Wing Sum Tam, et al.
Pageof 12